Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
UBS
McKinsey
Harvard Business School
Moodys
QuintilesIMS
Citi
Cantor Fitzgerald

Generated: October 19, 2018

DrugPatentWatch Database Preview

CICLOPIROX Drug Profile

« Back to Dashboard

When do Ciclopirox patents expire, and when can generic versions of Ciclopirox launch?

Ciclopirox is a drug marketed by Fougera Pharms, G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Cnty Line Pharms, Glenmark Generics, Paddock Llc, Actavis Mid Atlantic, Perrigo Co, Teligent Pharma Inc, Akorn, Apotex Inc, G And W Labs, Hi Tech Pharma, Ingenus Pharms Llc, Mylan Pharms Inc, Taro Pharm Inds, Teva Pharms, and Tolmar. and is included in twenty-eight NDAs. There is one patent protecting this drug.

The generic ingredient in CICLOPIROX is ciclopirox. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

Drug patent expirations by year for CICLOPIROX
Synonyms for CICLOPIROX
(6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone)
1-hydroxy-4-methyl-6-cyclohexyl-2-pyridone
19W019ZDRJ
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methyl-2-pyridone
2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
2-azanylethanol;6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one
2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-
2(1H)-Pyridone, 6-cyclohexyl-1-hydroxy-4-methyl-
29342-05-0
342C050
6-Cyclohexenyl-1-hydroxy-4-methyl-2(1h)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one
6-CYCLOHEXYL-1-HYDROXY-4-METHYL-1H-PYRIDIN-2-ONE
6-Cyclohexyl-1-hydroxy-4-methyl-2-(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-2-pyridinone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridinone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone #
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-pyridin-2-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one
6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one
A819878
AB00053438_09
AB00053438_10
AB00053438_11
AB0011605
AB06517
AB2000628
AC-24195
AC1L1EDN
AJ-07970
AK544043
AKOS015895717
AN-773
Batrafen
Batrafen (TN)
Batrafen; Loprox;Mycoster;Stieprox;HOE 296b;Penlac
BC205517
BDBM66087
BG0571
BIDD:GT0080
BPBio1_000641
BSPBio_000581
BSPBio_002041
C-10474
C12H17NO2
CC-25776
CHEBI:453011
CHEMBL1413
Ciclopirox (Penlac)
Ciclopirox (USP/INN)
Ciclopirox [USAN:BAN:INN]
Ciclopirox [USAN:USP:INN:BAN]
Ciclopirox gel
Ciclopirox Olamin
Ciclopirox-Olamin
Ciclopiroxum
Ciclopiroxum [INN-Latin]
cid_38911
CNL8
CS-2561
CTK4G3143
cyclopirox
cyclopyroxolamine
D03488
D07GRH
Dafnegin-CSC
DB01188
DR000350
DTXSID9048564
EINECS 249-577-2
FT-0602961
HE332472
HMS3656I12
HOE 296b
HOE-296
HOE-296b
HY-B0450
I06-0862
KB-270156
KBio3_001261
KBioGR_000816
KS-00000L3N
KS-5085
KSC563C4H
Loprox
Loprox (TN)
Loprox cream
Loprox Gel
Loprox Shampoo
LS-174247
MFCD00599441
MLS002153867
MolPort-003-845-943
Mycoster
NCGC00017112-04
NCGC00017112-05
NCGC00017112-06
NCGC00017112-08
NCGC00017112-11
NCGC00178850-01
NCGC00178850-02
Penlac
Penlac (TN)
Penlac nail lacquer
Prestwick0_000541
Prestwick1_000541
Prestwick2_000541
Prestwick3_000541
s2528
SBI-0206690.P002
SC-17361
SCHEMBL34424
SCKYRAXSEDYPSA-UHFFFAOYSA-N
SMR001233223
SPBio_000252
SPBio_002502
Spectrum2_000146
Spectrum3_000351
Spectrum4_000288
Spectrum5_000747
SR-05000001589
SR-05000001589-5
Stieprox
Stieprox (TN)
Terit
TL8002303
UNII-19W019ZDRJ
W-106995
ZINC1145

US Patents and Regulatory Information for CICLOPIROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro CICLOPIROX ciclopirox SUSPENSION;TOPICAL 077092-001 Aug 10, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms CICLOPIROX ciclopirox CREAM;TOPICAL 076435-001 Dec 29, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs CICLOPIROX ciclopirox SOLUTION;TOPICAL 078233-001 Sep 18, 2007 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms CICLOPIROX ciclopirox SOLUTION;TOPICAL 078079-001 Sep 18, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms CICLOPIROX ciclopirox GEL;TOPICAL 077896-001 Jun 10, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for CICLOPIROX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms CICLOPIROX ciclopirox GEL;TOPICAL 020519-001 Jul 21, 1997 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms CICLOPIROX ciclopirox GEL;TOPICAL 020519-001 Jul 21, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Premature patent expiration for: CICLOPIROX

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
➤ Sign Up CICLOPIROX ➤ Sign Up

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
UBS
McKinsey
Harvard Business School
Moodys
QuintilesIMS
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.